Course Directors

Hooman Djaladat, MD, MS

Norris Cancer Center, University of Southern California, Los Angeles, CA

Winston Tan, MSHPEd, MD

Mayo Clinic, Jacksonville, FL

Accredited by

American Society of Clinical Oncology

Course Description

Learning Objectives:
- Describe the standard first-line treatments for patients with muscle-invasive bladder cancer, including those ineligible for cisplatin
- Evaluate a patient’s eligibility for radical cystectomy, and assess the pros and cons of different urinary diversion techniques
- Discuss second-line treatment options if disease progression occurs
- Apply knowledge learned to the care of patients with muscle-invasive bladder cancer

Activity Details

Credit Types:CME / MOC / CE
Credit Amount:1.50 Credits
Release Date:2020-Jan-15
Expiration Date:2022-Jan-15
Estimated Time for Completion:1 hour and 30 minutes
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.